COMPANY
HIKMA FARMACEUTICA (PORTUGAL) SA
HIKMA FARMACEUTICA (PORTUGAL) SA: marketing authorisation holder for Colistin, Daptomycin, Vancomycin, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Colistin | COLISTIMETHATE SODIUM 1 MIU POWDER FOR NEBULISER SOLUTION, PL 15413/0143, Authorised Regulator MHRA |
|---|---|
| Colistin | COLISTIMETHATE SODIUM 1 MIU POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 15413/0135, Authorised Regulator MHRA |
| Colistin | COLISTIMETHATE SODIUM 2 MIU POWDER FOR NEBULISER SOLUTION, PL 15413/0164, Authorised Regulator MHRA |
| Colistin | COLISTIMETHATE SODIUM 2 MIU POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 15413/0163, Authorised Regulator MHRA |
| Daptomycin | DAPTOMYCIN 350 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 15413/0126, Authorised Regulator MHRA |
| Daptomycin | DAPTOMYCIN 350MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 15413/0173, Authorised Regulator MHRA |
| Daptomycin | DAPTOMYCIN 500 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 15413/0127, Authorised Regulator MHRA |
| Daptomycin | DAPTOMYCIN 500MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 15413/0174, Authorised Regulator MHRA |
| Vancomycin | VANCOMYCIN, 1000 MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 15413/0008, Authorised Regulator MHRA |
| Vancomycin | VANCOMYCIN, 500 MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 15413/0001, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.